237 related articles for article (PubMed ID: 32553932)
1. The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.
Armstrong PW; Bogaerts K; Welsh R; Sinnaeve PR; Goldstein P; Pages A; Danays T; Van de Werf F;
Am Heart J; 2020 Aug; 226():140-146. PubMed ID: 32553932
[TBL] [Abstract][Full Text] [Related]
2. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
Bainey KR; Armstrong PW; Zheng Y; Brass N; Tyrrell BD; Leung R; Westerhout CM; Welsh RC
Circ Cardiovasc Interv; 2019 Oct; 12(10):e008059. PubMed ID: 31607152
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
Chen Z; Wang D; Ma M; Li C; Wan Z; Zhang L; Zhu Y; Wang M; Wang H; He S; Peng Y; Wei J; Huang B; He Y;
Clin Cardiol; 2021 Apr; 44(4):455-462. PubMed ID: 33634478
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.
Rashid MK; Guron N; Bernick J; Wells GA; Blondeau M; Chong AY; Dick A; Froeschl MPV; Glover CA; Hibbert B; Labinaz M; Marquis JF; Osborne C; So DY; Le May MR
JACC Cardiovasc Interv; 2016 Oct; 9(19):2014-2020. PubMed ID: 27712737
[TBL] [Abstract][Full Text] [Related]
9. Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times.
van Diepen S; Zheng Y; Senaratne JM; Tyrrell BD; Das D; Thiele H; Henry TD; Bainey KR; Welsh RC
Circ Cardiovasc Interv; 2024 Feb; 17(2):e013415. PubMed ID: 38293830
[TBL] [Abstract][Full Text] [Related]
10. Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
Jamal J; Idris H; Faour A; Yang W; McLean A; Burgess S; Shugman I; Wales K; O'Loughlin A; Leung D; Mussap CJ; Juergens CP; Lo S; French JK
Eur Heart J; 2023 Feb; 44(6):516-528. PubMed ID: 36459120
[TBL] [Abstract][Full Text] [Related]
11. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F;
Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043
[TBL] [Abstract][Full Text] [Related]
12. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
Danchin N; Popovic B; Puymirat E; Goldstein P; Belle L; Cayla G; Roubille F; Lemesle G; Ferrières J; Schiele F; Simon T;
Eur Heart J; 2020 Feb; 41(7):858-866. PubMed ID: 31539043
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI.
Victor SM; Vijayakumar S; Alexander T; Bahuleyan CG; Srinivas A; Selvamani S; Priya SM; Kamaleswari K; Mullasari AS
Indian Heart J; 2016; 68(2):169-73. PubMed ID: 27133326
[TBL] [Abstract][Full Text] [Related]
14. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
Armstrong PW; Zheng Y; Westerhout CM; Rosell-Ortiz F; Sinnaeve P; Lambert Y; Lopes RD; Bluhmki E; Danays T; Van de Werf F;
Am Heart J; 2015 Jun; 169(6):890-898.e1. PubMed ID: 26027628
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Pharmaco-Invasive Strategy Using Half-Dose Recombinant Human Prourokinase in Patients with ST-Segment Elevation Myocardial Infarction During Hospitalization.
Dou J; Gao J; Yang H; Guo R; Jiang C; Guo J; Luo D
Clin Appl Thromb Hemost; 2024; 30():10760296231221772. PubMed ID: 38166398
[TBL] [Abstract][Full Text] [Related]
16. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
[TBL] [Abstract][Full Text] [Related]
17. Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India.
Alex AG; Lahiri A; ; Geevar T; George OK
J Postgrad Med; 2018; 64(2):80-85. PubMed ID: 29067927
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.
Zubaid M; Khraishah H; Alahmad B; Rashed W; Ridha M; Alenezi F; Aljarralah M; Al-Marri K; Almutairi M; Althalji K; Alfaddagh A
Ann Glob Health; 2020 Feb; 86(1):13. PubMed ID: 32064231
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway.
Jortveit J; Pripp AH; Halvorsen S
Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):442-451. PubMed ID: 34038535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
